Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
暂无分享,去创建一个
John F. Flaherty | W. Seto | H. Janssen | A. Chowdhury | K. Kitrinos | A. Gaggar | K. Agarwal | R. Mehta | E. Gane | J. McHutchison | Y. Lim | G. Subramanian | J. Flaherty | Lanjia Lin | H. Chan | W. Chuang | Hyung Joon Kim | T. Tsang | S. Acharya | S. Fung | A. Hui | Chi-yi Chen | B. Massetto | W. Seto | J. Mchutchison